Evidence map›Paper›PMID 30014240›Full record

ArticleJournal of neurology2018

Step length predicts executive dysfunction in Parkinson's disease: a 3-year prospective study.

Marianna Amboni, Luigi Iuppariello, Alessandro Iavarone, Alfonso Fasano, Raffaele Palladino, Rosaria Rucco, Marina Picillo, Ilaria Lista, Pasquale Varriale, Carmine Vitale and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. A Double-Blind, Randomized, Placebo-Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's Disease.Movement disorders : official journal of the Movement Disorder Society · 2023
    Trial
  3. Trial
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 3 countries.

Marianna AmboniDepartment of Medicine and Surgery "Scuola Medica Salernitana", Center for Neurodegenerative Diseases, University of Salerno, Via S. Allende, 1, 84081, Baronissi, SA, Italy. marianna.amboni@gmail.com.ORCID http://orcid.org/0000-0002-6988-8197
Luigi IupparielloDIETI, University of Naples, "Federico II", Naples, Italy.
Alessandro IavaroneNeurological and Stroke Unit, Centro Traumatologico Ortopedico Hospital AORN "Ospedali dei Colli", Naples, Italy.
Alfonso FasanoMorton and Gloria Shulman Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson's Disease, Division of Neurology, Toronto Western Hospital, UHN, University of Toronto, Toronto, ON, Canada.
Raffaele PalladinoDepartment of Primary Care and Public Health, Imperial College, London, UK.
Rosaria RuccoIstituto di Diagnosi e Cura Hermitage-Capodimonte, Via Cupa delle Tozzole, 2, 80131, Naples, Italy.
Marina PicilloDepartment of Medicine and Surgery "Scuola Medica Salernitana", Center for Neurodegenerative Diseases, University of Salerno, Via S. Allende, 1, 84081, Baronissi, SA, Italy.
Ilaria ListaDepartment of Motor Sciences and Wellness, University of Naples Parthenope, Naples, Italy.
Pasquale VarrialeIstituto di Diagnosi e Cura Hermitage-Capodimonte, Via Cupa delle Tozzole, 2, 80131, Naples, Italy.
Carmine VitaleIstituto di Diagnosi e Cura Hermitage-Capodimonte, Via Cupa delle Tozzole, 2, 80131, Naples, Italy.
Mario CesarelliDIETI, University of Naples, "Federico II", Naples, Italy.
Giuseppe SorrentinoIstituto di Diagnosi e Cura Hermitage-Capodimonte, Via Cupa delle Tozzole, 2, 80131, Naples, Italy.
Paolo BaroneDepartment of Medicine and Surgery "Scuola Medica Salernitana", Center for Neurodegenerative Diseases, University of Salerno, Via S. Allende, 1, 84081, Baronissi, SA, Italy.
Parthenope University of Naples · ITUniversity of Salerno · ITCTO Hospital · ITFederico II University Hospital · ITSantobono Children's Hospital · ITUniversity of Naples Federico II · ITUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cognition and gait appear to be closely related. The chronological interplay between cognitive decline and gait dysfunction is not fully understood. The aim of the present prospective study is investigating whether the dysfunction of specific gait parameters, during specific task and medication conditions, may predict subsequent cognitive impairment in Parkinson's disease (PD). We evaluated cognition and gait in 39 Parkinsonian patients at an initial assessment and after 3 years. Cognitive performance was evaluated with a neuropsychological battery designed to assess memory, executive/attention, and visuospatial domains. Gait was investigated using a gait analysis system during both the off and on states in the following conditions: (1) normal gait; (2) motor dual task; and (3) cognitive dual task. We used regression models to determine whether gait predicts subsequent cognitive dysfunction. Overall, the cognitive test scores were stable over time with the exception of the executive/attention scores, whereas all gait parameters declined. The step length during the cognitive dual task during the on state at the initial evaluation was the only significant predictor of executive/attention domain dysfunction at follow up. The results were confirmed when executive/attention dysfunction at the initial assessment evaluation was included in the regression model as a covariate. Our longitudinal study offers additional insight into the progression of gait dysfunction, and its chronological relationship with cognitive dysfunction in PD patients. In particular, the present study indicates that step length during a cognitive task when on medication is an independent predictor of future executive/attention decline.

Indexed as

Executive FunctionGaitAgedAntiparkinson AgentsBiomechanical PhenomenaCognitive DysfunctionDisease ProgressionFemaleFollow-Up StudiesHumansLevodopaLongitudinal StudiesMaleMiddle AgedParkinson DiseasePrognosisAntiparkinson AgentsLevodopaCognitionExecutive dysfunctionGaitGait analysisParkinson’s disease

Identifiers

PMID30014240
OpenAlexW2884417535

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.